PHARMA: McKinell’s over-Exubera-nce

Diabetes sufferers will have to wait a longer for Exubera, an inhaled insulin drug that supporters say transform the lives of people with the condition. Pfizer shares soared this morning after CEO Hank McKinnell said the drug has received FDA approval.

Turns out Mckinnell was just excited…..or perhaps over – Exubera-nt?

Anyway the stock market seems to think that he knows something.



Categories: Uncategorized

Tagged as: ,